Somnee

Launched in 2022 by Dr. Matthew Walker (author of the NYT bestseller, Why We Sleep) and a team of UC Berkeley neuroscientists, Somnee is the first ever personalized diagnostic-therapeutic for sleep. Users wear the smart sleep headband before bedtime as they read, meditate, or begin to drift off into sleep. Over the first 2–7 nights of use, it maps a user’s unique brainwave patterns. After establishing this baseline, Somnee personalizes an electrical stimulation to the user that gently guides their brain into its optimal state for sleep, night after night–regardless of choices like eating a late dinner, watching TV, or going on social media, which impact the brain’s sleep readiness. Somnee stands to replace popular sleep aids. Sleep medications can be habit-forming and have side effects like morning drowsiness. CBTi’s efficacy varies greatly by provider. Somnee is safe, sustainable, convenient and easy. Backed by over five years of research and development, it has been clinically validated to outperform melatonin by 4X, helping users fall asleep in half the time, extend sleep by over 30 minutes, and reduce nighttime disruptions by a third. Somnee’s mission is to fundamentally improve the human experience by restoring high-quality sleep: an overlooked cornerstone of health, longevity, and performance. Somnee is setting the standard for a new category of wellness technology that doesn’t just track sleep, but actively improves it. With tested performance, a consumer-friendly design, and applications across healthcare, wellness, and longevity, Somnee represents the future of sleep solutions.